RT Journal Article
SR Electronic
T1 A Theoretical and Experimental Study of the Semirigid Cholinergic Agonist 3-Acetoxyquinuclidine
JF Molecular Pharmacology
JO Mol Pharmacol
FD American Society for Pharmacology and Experimental Therapeutics
SP 671
OP 689
VO 11
IS 5
A1 HAREL WEINSTEIN
A1 SAUL MAAYANI
A1 SHALOM SREBRENIK
A1 SASSON COHEN
A1 MORDECHAI SOKOLOVSKY
YR 1975
UL http://molpharm.aspetjournals.org/content/11/5/671.abstract
AB The interaction of the two enantiomens of 3-acetoxyquinuclidine (3-AcQ) and of its N-methyl derivative with the cholinergic receptor and with cholinesterases was investigated experimentally in systems which respond to acetylcholine (ACh). Molecular structural factors which are conducive to the well-defined ACh-like activity were studied by quantum mechanical methods. The flexible moiety in the semirigid structure of 3-AcQ was shown to permit molecular rearrangements, as required for receptor activation, and to adopt an ACh-like conformation in the energetically preferred geometry. The interaction pharmacophore of the active species, defined by the electrostatic potential fields generated in their surroundings, revealed a reactivity pattern identical with that of ACh. The interaction pharmacophore of the N-methyl derivative of 3-AcQ was shown to be much less compatible with the requirements for ACh-like activity. The structural correlation between the ACh-like pattern of the drugs and the biological activity of related psychotropic-anticholinergic amino esters is discussed.